SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001279569-24-001116
Filing Date
2024-09-16
Accepted
2024-09-13 17:33:33
Documents
15
Period of Report
2024-09-13
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K form8k.htm   iXBRL 8-K 25114
2 NEWS RELEASE DATED SEPTEMBER 13, 2024 ex991.htm EX-99.1 21524
3 GRAPHIC logo.jpg GRAPHIC 9119
  Complete submission text file 0001279569-24-001116.txt   240636

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA epix-20240913.xsd EX-101.SCH 3021
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE epix-20240913_lab.xml EX-101.LAB 34240
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE epix-20240913_pre.xml EX-101.PRE 22363
18 EXTRACTED XBRL INSTANCE DOCUMENT form8k_htm.xml XML 3772
Mailing Address SUITE 720 999 WEST BROADWAY VANCOUVER A1 V5Z 1K5
Business Address SUITE 720 999 WEST BROADWAY VANCOUVER A1 V5Z 1K5 (778) 331-0962
ESSA Pharma Inc. (Filer) CIK: 0001633932 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 0930
Type: 8-K | Act: 34 | File No.: 001-37410 | Film No.: 241298815
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)